Botanical Drugs
Total Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
2,028
NCT00501371
MCS in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia
Phase: Phase 3
Role: Lead Sponsor
Start: Jul 31, 2007
Completion: Oct 31, 2009
NCT01016340
Efficacy and Safety of MCS-5 in Treating Male Oligoasthenospermia
Phase: Phase 2
Start: Dec 31, 2009
Completion: Jun 30, 2013
NCT01002664
Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms
Start: May 31, 2010
Completion: Jun 30, 2014
NCT01002417
MCS in the Treatment of Lower Urinary Tract Symptoms
Phase: Phase 2/3
Start: Jul 31, 2010
Completion: Feb 28, 2014
NCT01002274
Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms
Start: Aug 31, 2010
NCT01002222
Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c)
Start: Jan 31, 2011
NCT01003171
Pharmacokinetics of MCS in Healthy Volunteers
Phase: Phase 1
Start: Aug 31, 2011
Completion: Dec 31, 2012
NCT02042807
To Evaluate the Effect of MCS® in Prostate Cancer Prevention
Start: Oct 31, 2014
Completion: Dec 31, 2024
NCT02426216
Molecular Effects of a Multi-carotenoids (MCS) New Agent on Prostate Cancer Chemoprevention
Phase: N/A
Role: Collaborator
Start: Mar 31, 2015
Completion: Jul 31, 2018
Loading map...